Pharmaceutical Institute, School of Pharmacy, Henan University, Kaifeng, China.
Kaifeng Key Lab for Application of Local Dendranthema morifolium in Food & Drug, Kaifeng, China.
Pharm Biol. 2021 Dec;59(1):1378-1387. doi: 10.1080/13880209.2021.1986077.
Acetaminophen (APAP) overdose is the leading cause of drug-induced liver injury. , a variety of Ramat. (Asteraceae), has potential hepatoprotective effect. However, the mechanism is not clear yet.
To investigate the hepatoprotective activity and mechanism of flower ethanol extract (BZE) on APAP-induced rats based on network pharmacology.
Potential pathways of BZE were predicted by network pharmacology. Male Sprague-Dawley rats were pre-treated with BZE (110, 220 and 440 mg/kg, i.g.) for eight days, and then APAP (800 mg/kg, i.g.) was used to induce liver injury. After 24 h, serum and liver were collected for biochemical detection and western blot measurement.
Network pharmacology indicated that liver-protective effect of BZE was associated with its antioxidant and anti-apoptotic efficacy. APAP-induced liver pathological change was alleviated, and elevated serum AST and ALT were reduced by BZE (440 mg/kg) (from 66.45 to 22.64 U/L and from 59.59 to 17.49 U/L, respectively). BZE (440 mg/kg) reduced the ROS to 65.50%, and upregulated SOD and GSH by 212.92% and 175.38%, respectively. In addition, BZE (440 mg/kg) increased levels of p-AMPK, p-GSK3β, HO-1 and NQO1, ranging from 1.66- to 10.29-fold compared to APAP group, and promoted nuclear translocation of Nrf2. BZE also inhibited apoptosis induced by APAP through the PI3K-Akt pathway and restored the ability of mitochondrial biogenesis.
Our study demonstrated that BZE protected rats from APAP-induced liver injury through antioxidant and anti-apoptotic pathways, suggesting BZE could be further developed as a potential liver-protecting agent.
对乙酰氨基酚(APAP)过量是药物性肝损伤的主要原因。 , 一种 Ramat. (菊科), 具有潜在的肝保护作用。然而,其机制尚不清楚。
基于网络药理学研究 花乙醇提取物(BZE)对 APAP 诱导的大鼠的肝保护活性和机制。
通过网络药理学预测 BZE 的潜在途径。雄性 Sprague-Dawley 大鼠连续 8 天经口给予 BZE(110、220 和 440 mg/kg)预处理,然后用 APAP(800 mg/kg,经口)诱导肝损伤。24 h 后收集血清和肝脏进行生化检测和 Western blot 测量。
网络药理学表明,BZE 的肝保护作用与其抗氧化和抗凋亡作用有关。BZE(440 mg/kg)减轻了 APAP 诱导的肝病理变化,降低了升高的血清 AST 和 ALT(分别从 66.45 降至 22.64 U/L 和从 59.59 降至 17.49 U/L)。BZE(440 mg/kg)将 ROS 降低到 65.50%,并分别将 SOD 和 GSH 上调 212.92%和 175.38%。此外,BZE(440 mg/kg)使 p-AMPK、p-GSK3β、HO-1 和 NQO1 的水平分别增加了 1.66 至 10.29 倍,与 APAP 组相比,促进了核内 Nrf2 的易位。BZE 还通过 PI3K-Akt 通路抑制 APAP 诱导的凋亡,并恢复线粒体生物发生的能力。
本研究表明,BZE 通过抗氧化和抗凋亡途径保护大鼠免受 APAP 诱导的肝损伤,提示 BZE 可进一步开发为潜在的肝保护剂。